HEADER ANTIMICROBIAL PROTEIN 04-OCT-17 5YIG TITLE CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIA PARE WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: DNA TOPOISOMERASE 4 SUBUNIT B; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: TOPOISOMERASE IV SUBUNIT B; COMPND 5 EC: 5.99.1.3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOCOCCUS PNEUMONIAE GA47502; SOURCE 3 ORGANISM_TAXID: 760839; SOURCE 4 GENE: PARE, SPAR98_0871; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI K-12; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 83333; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: K-12 KEYWDS INHIBITOR, ANTIMICROBIAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.CHERIAN,Y.TAN,J.HILL REVDAT 2 27-MAR-24 5YIG 1 REMARK REVDAT 1 05-SEP-18 5YIG 0 JRNL AUTH S.Y.HO,W.WANG,F.M.NG,Y.X.WONG,Z.Y.POH,S.W.E.TAN,S.H.ANG, JRNL AUTH 2 S.S.LIEW,Y.S.JOYNER WONG,Y.TAN,A.POULSEN,V.PENDHARKAR, JRNL AUTH 3 K.SANGTHONGPITAG,J.MANCHESTER,G.BASARAB,J.HILL,T.H.KELLER, JRNL AUTH 4 J.CHERIAN JRNL TITL DISCOVERY OF DUAL GYRB/PARE INHIBITORS ACTIVE AGAINST JRNL TITL 2 GRAM-NEGATIVE BACTERIA. JRNL REF EUR J MED CHEM V. 157 610 2018 JRNL REFN ISSN 1768-3254 JRNL PMID 30125722 JRNL DOI 10.1016/J.EJMECH.2018.08.025 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.93 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 21230 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.980 REMARK 3 FREE R VALUE TEST SET COUNT : 2119 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.9367 - 6.8904 0.96 1226 138 0.1728 0.1955 REMARK 3 2 6.8904 - 5.4754 1.00 1294 148 0.1725 0.2300 REMARK 3 3 5.4754 - 4.7851 1.00 1275 141 0.1545 0.2089 REMARK 3 4 4.7851 - 4.3484 0.99 1290 146 0.1466 0.1969 REMARK 3 5 4.3484 - 4.0372 0.99 1289 141 0.1763 0.2134 REMARK 3 6 4.0372 - 3.7994 0.99 1283 140 0.1881 0.2464 REMARK 3 7 3.7994 - 3.6093 0.97 1206 134 0.2291 0.2674 REMARK 3 8 3.6093 - 3.4523 0.98 1293 140 0.2402 0.2471 REMARK 3 9 3.4523 - 3.3195 0.99 1278 142 0.2447 0.3319 REMARK 3 10 3.3195 - 3.2051 0.99 1281 141 0.2508 0.2942 REMARK 3 11 3.2051 - 3.1049 0.99 1259 137 0.2595 0.2840 REMARK 3 12 3.1049 - 3.0162 0.99 1282 143 0.2575 0.3290 REMARK 3 13 3.0162 - 2.9368 0.99 1288 146 0.2510 0.3616 REMARK 3 14 2.9368 - 2.8652 1.00 1295 139 0.2607 0.3268 REMARK 3 15 2.8652 - 2.8001 0.99 1272 143 0.2343 0.2917 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.370 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.630 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.41 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.62 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 3185 REMARK 3 ANGLE : 0.991 4338 REMARK 3 CHIRALITY : 0.030 495 REMARK 3 PLANARITY : 0.005 552 REMARK 3 DIHEDRAL : 14.348 1232 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: CHAIN A REMARK 3 SELECTION : CHAIN B REMARK 3 ATOM PAIRS NUMBER : 1694 REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURE FACTOR FILE CONTAINS REMARK 3 FRIEDEL PAIRS IN I_PLUS/MINUS COLUMNS REMARK 4 REMARK 4 5YIG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-OCT-17. REMARK 100 THE DEPOSITION ID IS D_1300005321. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : BRUKER AXS MICROSTAR REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU AFC-5R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SAINT V8.34A REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21230 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 35.934 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 2.800 REMARK 200 R MERGE (I) : 0.17900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.7200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.87 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.6 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M SODIUM ACETATE, 18-22% PEG 3350, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.99000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 17 REMARK 465 GLY A 105 REMARK 465 GLY A 106 REMARK 465 LYS A 107 REMARK 465 PHE A 108 REMARK 465 GLY A 109 REMARK 465 GLN A 110 REMARK 465 GLY A 111 REMARK 465 GLY A 112 REMARK 465 TYR A 113 REMARK 465 LYS A 114 REMARK 465 THR A 115 REMARK 465 SER A 116 REMARK 465 GLY A 117 REMARK 465 GLY A 118 REMARK 465 LEU A 119 REMARK 465 HIS A 120 REMARK 465 GLY A 121 REMARK 465 GLY B 105 REMARK 465 GLY B 106 REMARK 465 LYS B 107 REMARK 465 PHE B 108 REMARK 465 GLY B 109 REMARK 465 GLN B 110 REMARK 465 GLY B 111 REMARK 465 GLY B 112 REMARK 465 TYR B 113 REMARK 465 LYS B 114 REMARK 465 THR B 115 REMARK 465 SER B 116 REMARK 465 GLY B 117 REMARK 465 GLY B 118 REMARK 465 LEU B 119 REMARK 465 HIS B 120 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN B 17 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 37 -151.74 -101.25 REMARK 500 HIS A 88 -133.62 -113.66 REMARK 500 HIS A 103 40.54 -89.65 REMARK 500 LYS A 205 151.76 66.35 REMARK 500 ASP B 37 -152.45 -103.50 REMARK 500 HIS B 88 -131.28 -112.85 REMARK 500 HIS B 103 41.06 -89.75 REMARK 500 LYS B 205 152.01 65.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 54B A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 54B B 301 DBREF 5YIG A 17 226 UNP G6JAH7 G6JAH7_STREE 17 226 DBREF 5YIG B 17 226 UNP G6JAH7 G6JAH7_STREE 17 226 SEQRES 1 A 210 GLN VAL LEU GLU GLY LEU ASP ALA VAL ARG LYS ARG PRO SEQRES 2 A 210 GLY MET TYR ILE GLY SER THR ASP GLY ALA GLY LEU HIS SEQRES 3 A 210 HIS LEU VAL TRP GLU ILE VAL ASP ASN ALA VAL ASP GLU SEQRES 4 A 210 ALA LEU SER GLY PHE GLY ASP ARG ILE ASP VAL THR ILE SEQRES 5 A 210 ASN LYS ASP GLY SER LEU THR VAL GLN ASP HIS GLY ARG SEQRES 6 A 210 GLY MET PRO THR GLY MET HIS ALA MET GLY ILE PRO THR SEQRES 7 A 210 VAL GLU VAL ILE PHE THR ILE LEU HIS ALA GLY GLY LYS SEQRES 8 A 210 PHE GLY GLN GLY GLY TYR LYS THR SER GLY GLY LEU HIS SEQRES 9 A 210 GLY VAL GLY SER SER VAL VAL ASN ALA LEU SER SER TRP SEQRES 10 A 210 LEU GLU VAL GLU ILE THR ARG ASP GLY ALA VAL TYR LYS SEQRES 11 A 210 GLN ARG PHE GLU ASN GLY GLY LYS PRO VAL THR THR LEU SEQRES 12 A 210 LYS LYS ILE GLY THR ALA LEU LYS SER LYS THR GLY THR SEQRES 13 A 210 LYS VAL THR PHE MET PRO ASP ALA THR ILE PHE SER THR SEQRES 14 A 210 THR ASP PHE LYS TYR ASN THR ILE SER GLU ARG LEU ASN SEQRES 15 A 210 GLU SER ALA PHE LEU LEU LYS ASN VAL THR LEU SER LEU SEQRES 16 A 210 THR ASP LYS ARG THR ASP GLU ALA ILE GLU PHE HIS TYR SEQRES 17 A 210 GLU ASN SEQRES 1 B 210 GLN VAL LEU GLU GLY LEU ASP ALA VAL ARG LYS ARG PRO SEQRES 2 B 210 GLY MET TYR ILE GLY SER THR ASP GLY ALA GLY LEU HIS SEQRES 3 B 210 HIS LEU VAL TRP GLU ILE VAL ASP ASN ALA VAL ASP GLU SEQRES 4 B 210 ALA LEU SER GLY PHE GLY ASP ARG ILE ASP VAL THR ILE SEQRES 5 B 210 ASN LYS ASP GLY SER LEU THR VAL GLN ASP HIS GLY ARG SEQRES 6 B 210 GLY MET PRO THR GLY MET HIS ALA MET GLY ILE PRO THR SEQRES 7 B 210 VAL GLU VAL ILE PHE THR ILE LEU HIS ALA GLY GLY LYS SEQRES 8 B 210 PHE GLY GLN GLY GLY TYR LYS THR SER GLY GLY LEU HIS SEQRES 9 B 210 GLY VAL GLY SER SER VAL VAL ASN ALA LEU SER SER TRP SEQRES 10 B 210 LEU GLU VAL GLU ILE THR ARG ASP GLY ALA VAL TYR LYS SEQRES 11 B 210 GLN ARG PHE GLU ASN GLY GLY LYS PRO VAL THR THR LEU SEQRES 12 B 210 LYS LYS ILE GLY THR ALA LEU LYS SER LYS THR GLY THR SEQRES 13 B 210 LYS VAL THR PHE MET PRO ASP ALA THR ILE PHE SER THR SEQRES 14 B 210 THR ASP PHE LYS TYR ASN THR ILE SER GLU ARG LEU ASN SEQRES 15 B 210 GLU SER ALA PHE LEU LEU LYS ASN VAL THR LEU SER LEU SEQRES 16 B 210 THR ASP LYS ARG THR ASP GLU ALA ILE GLU PHE HIS TYR SEQRES 17 B 210 GLU ASN HET 54B A 301 42 HET 54B B 301 42 HETNAM 54B 1-ETHYL-3-[5-[2-[(1S,5R)-3-METHYL-3,8- HETNAM 2 54B DIAZABICYCLO[3.2.1]OCTAN-8-YL]-5-(2-OXIDANYLIDENE-3H- HETNAM 3 54B 1,3,4-OXADIAZOL-5-YL)PYRIDIN-3-YL]-4-[4- HETNAM 4 54B (TRIFLUOROMETHYL)-1,3-THIAZOL-2-YL]PYRIDIN-2-YL]UREA FORMUL 3 54B 2(C26 H26 F3 N9 O3 S) FORMUL 5 HOH *6(H2 O) HELIX 1 AA1 LEU A 22 ARG A 28 1 7 HELIX 2 AA2 PRO A 29 GLY A 34 1 6 HELIX 3 AA3 ASP A 37 LEU A 57 1 21 HELIX 4 AA4 HIS A 88 ILE A 92 5 5 HELIX 5 AA5 PRO A 93 ILE A 101 1 9 HELIX 6 AA6 GLY A 123 LEU A 130 1 8 HELIX 7 AA7 LYS A 189 LYS A 205 1 17 HELIX 8 AA8 LEU B 22 ARG B 28 1 7 HELIX 9 AA9 PRO B 29 GLY B 34 1 6 HELIX 10 AB1 ASP B 37 LEU B 57 1 21 HELIX 11 AB2 HIS B 88 ILE B 92 5 5 HELIX 12 AB3 PRO B 93 ILE B 101 1 9 HELIX 13 AB4 VAL B 122 LEU B 130 1 9 HELIX 14 AB5 LYS B 189 LYS B 205 1 17 SHEET 1 AA1 3 LYS A 154 PRO A 155 0 SHEET 2 AA1 3 ALA A 143 GLU A 150 -1 N GLU A 150 O LYS A 154 SHEET 3 AA1 3 LYS A 160 THR A 164 -1 O ILE A 162 N VAL A 144 SHEET 1 AA2 8 LYS A 154 PRO A 155 0 SHEET 2 AA2 8 ALA A 143 GLU A 150 -1 N GLU A 150 O LYS A 154 SHEET 3 AA2 8 SER A 131 ARG A 140 -1 N LEU A 134 O PHE A 149 SHEET 4 AA2 8 GLY A 171 PRO A 178 -1 O THR A 175 N GLU A 135 SHEET 5 AA2 8 LEU A 74 ASP A 78 -1 N VAL A 76 O VAL A 174 SHEET 6 AA2 8 ARG A 63 ILE A 68 -1 N THR A 67 O THR A 75 SHEET 7 AA2 8 THR A 208 ASP A 213 1 O SER A 210 N VAL A 66 SHEET 8 AA2 8 GLU A 218 PHE A 222 -1 O GLU A 218 N ASP A 213 SHEET 1 AA3 3 LYS B 154 PRO B 155 0 SHEET 2 AA3 3 ALA B 143 GLU B 150 -1 N GLU B 150 O LYS B 154 SHEET 3 AA3 3 LYS B 160 THR B 164 -1 O GLY B 163 N VAL B 144 SHEET 1 AA4 8 LYS B 154 PRO B 155 0 SHEET 2 AA4 8 ALA B 143 GLU B 150 -1 N GLU B 150 O LYS B 154 SHEET 3 AA4 8 SER B 131 ARG B 140 -1 N ILE B 138 O TYR B 145 SHEET 4 AA4 8 GLY B 171 PRO B 178 -1 O THR B 175 N GLU B 135 SHEET 5 AA4 8 LEU B 74 ASP B 78 -1 N VAL B 76 O VAL B 174 SHEET 6 AA4 8 ARG B 63 ILE B 68 -1 N THR B 67 O THR B 75 SHEET 7 AA4 8 THR B 208 ASP B 213 1 O THR B 212 N ILE B 68 SHEET 8 AA4 8 GLU B 218 PHE B 222 -1 O GLU B 218 N ASP B 213 SITE 1 AC1 12 ASN A 51 ASP A 54 GLU A 55 VAL A 76 SITE 2 AC1 12 ASP A 78 ARG A 81 MET A 83 ILE A 98 SITE 3 AC1 12 SER A 124 ARG A 140 THR A 172 HOH A 402 SITE 1 AC2 12 ASN B 51 ASP B 54 GLU B 55 VAL B 76 SITE 2 AC2 12 ASP B 78 ARG B 81 MET B 83 ILE B 98 SITE 3 AC2 12 SER B 124 THR B 172 HOH B 401 HOH B 402 CRYST1 43.394 61.980 84.824 90.00 99.03 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023045 0.000000 0.003664 0.00000 SCALE2 0.000000 0.016134 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011937 0.00000